By contrast, mutations that disrupt the SWI/SNF chromatin remodeling complex and mutations that activate the RAS/MAPK/PI3K-signaling cascade were most commonly observed at the transition to squamous cell carcinoma (Fig. 4b). Here, SMARCA1 is linked to squamous cell carcinoma.